Jeffrey Friedland is an investor, author, business executive and a thought leader in the global cannabis industry.
Mr. Friedland's latest book is Marijuana: The World's Most Misunderstood Plant.
He was an owner of two marijuana retail stores in Breckenridge and Crested Butte, and a cultivation facility south of Steamboat Springs, all in Colorado.
He was a founder and initial CEO of publicly-traded Nexien BioPharma Inc. (NTVA). The company is developing cannabinoid-based drugs under U.S. Food and Drug Administration (FDA) protocols.
Mr. Friedland was also a founder of Israel-based Israel Plant Sciences, a company focused on cannabis genetics and breeding.
Mr. Friedland has been the chief executive officer and a director of a NASDAQ listed financial services company, a director of a New York Stock Exchange-listed company, and the chairman of the supervisory board of a Hong Kong-based company with a stock market listing on the Frankfurt Stock Exchange.
Mr. Friedland has been a host of two television shows, Cannabis Insider TV and Marijuana Stocks of the Week.
Mr. Friedland has been featured or quoted in numerous publications including the Wall Street Journal, Reuters, the New York Times, Bloomberg Television, USA Today, Verslo Zinios (Lithuania), Vercernji (Croatia), International Business Times, the South China Morning Post, the Guam Daily Post, the Forward, the Jewish Week, Quartz, the Jakarta Globe, Israel Daily Television, BreitBart, NBC.com and Forbes.
Mr. Friedland has been a frequent speaker at conferences and events throughout North America, Europe and Asia, including speeches to individual and institutional investors, cannabis industry entrepreneurs, and business owners on the cannabis, hemp, and CBD industries.
Michael King-Sadick passionately believes in entrepreneurship and fostering innovation for companies of all sizes. One of his key passions and skills is assisting businesses, from early-stage growing companies to mid-cap as well as Fortune 500 companies with innovating, disrupting their industry, and most importantly identifying strategies to grow revenues.
Mr. King-Sadick’s background includes founding a licensing and online marketing company. He was able to grow the company’s profits twenty times in a short, four-year period through primarily new product development and strategic partnerships.
At the same time, as Mr. King-Sadick was building his licensing and online marketing company, as a senior growth executive, he assisted SilverEdge in implementing a business management software campaign for the entire hydroponics industry. For SilverEdge he fostered mutually beneficial relationships with major Industry wholesalers. He also took the lead for SilverEdge in launching a go-to-market solution for hydroponics businesses that resulted in the greatest amount of software revenue of any direct sales or channel strategy, While assisting SilverEdge Mr. King-Sadick also participated in assisting a number of early-stage, developmental-stage and growth stage cannabis companies. Key to his assistance to these companies was his ability to increase the level of professionalism and assist management in implementing “real-world” corporate strategies.
After his involvement with SilverEdge and the numerous cannabis companies, Mr. King-Sadick, as a corporate advisor, brought his talents to other companies. As president of his company, Vertical Solutions, he has assisted companies with sales automation, revenue modeling, and corporate strategy. These activities in assisting startups, venture capitalists, and multi-billion dollar revenue companies resulted in his development of a proprietary and unique toolset that can be implemented across numerous industries to enable companies to maximize their growth.
With a focus in healthcare technology consulting Mr. King-Sadick, as vice president of development for Silicon Mountain Technologies, he leads the company’s strategy and sales efforts. With a focus on workflow automation and new product launching, Silicon Mountain Technologies, counts among its clients Johnson & Johnson, St. Judes, BioMedGPS, RamGroup and RezDox.